Abstract
This chapter focuses on explaining the interaction between the hypothalamic–pituitary–ovarian axis, menstrual and oral contraceptive cycles with exercise. The intent herein is to give the basic physiology and endocrinology framework that allows the reader to understand the dynamic hormonal changes that occur within women as related to their reproductive systems in turn to also provide a contextual basis for the role of exercise to impact on the hormonal components of the female reproductive system. In so doing the goal is to prepare the reader for some of the in-depth discussions on female physiology-endocrinology and exercise in the subsequent chapters of this book.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Allaway HCM, Southmayd EA, De Souza MJ. The physiology of functional hypothalamic amenorrhea associated with energy deficiency in exercising women and in women with anorexia nervosa. Horm Mol Biol Clin Invest. 2016;25(2):91–119. https://doi.org/10.1515/HMBCI-2015-0053.
Apter D. Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin Endocrinol. 1980;12(2):107–20. https://doi.org/10.1111/J.1365-2265.1980.TB02125.X.
Apter D, Gemzell-Danielsson K, Hauck B, Rosen K, Zurth C. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Fertil Steril 2014;101(6). https://doi.org/10.1016/J.FERTNSTERT.2014.03.004
Bahamondes L, Bahamondes MV, Shulman LP. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Hum Reprod Update. 2015;21(5):640–51. https://doi.org/10.1093/HUMUPD/DMV023.
Baird DT, Glasier AF. Hormonal Contraception 2010;328(21):1543–49. https://doi.org/10.1056/NEJM199305273282108.
Barr NG. Managing adverse effects of hormonal contraceptives. Am Fam Phys 2010;82(12):1499–1506. https://www.aafp.org/afp/2010/1215/p1499.html
Bergin A, Tristan S, Terplan M, Gilliam ML, Whitaker AK. A missed opportunity for care: two-visit IUD insertion protocols inhibit placement. Contraception. 2012;86(6):694–7. https://doi.org/10.1016/J.CONTRACEPTION.2012.05.011.
Brant AR, Ye PP, Teng SJ, Lotke PS. Non-contraceptive benefits of hormonal contraception: Established benefits and new findings. Curr Obstet Gynecol Rep 2017;6(2):109–117. https://doi.org/10.1007/S13669-017-0205-3
Brynhildsen JO, Hammar J, Hammar ML. Does the menstrual cycle and use of oral contraceptives influence the risk of low back pain? A prospective study among female soccer players. Scand J Med Sci Sports. 1997;7(6):348–53. https://doi.org/10.1111/J.1600-0838.1997.TB00165.X.
Bunt JC. Metabolic actions of estradiol: significance for acute and chronic exercise responses. Med Sci Sports Exerc 1990;22(3):286–290. http://www.ncbi.nlm.nih.gov/pubmed/2199750.
Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med. 2012;9(9):2213–23. https://doi.org/10.1111/J.1743-6109.2012.02848.X.
Castellano JM, Navarro VM, Fernández-Fernández R, Nogueiras R, Tovar S, Roa J, Vazquez MJ, Vigo E, Casanueva FF, Aguilar E, Pinilla L, Dieguez C, Tena-Sempere M. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by Kisspeptin in Undernutrition. Endocrinology. 2005;146(9):3917–25. https://doi.org/10.1210/en.2005-0337.
Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, Jamieson DJ. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;216(5):489.e1-489.e7. https://doi.org/10.1016/J.AJOG.2016.12.019.
Chi, IC. The safety and efficacy issues of progestin-only oral contraceptives—An epidemiologic perspective. Contraception 1993;47(1):1–21. https://doi.org/10.1016/0010-7824(93)90105-G.
Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267(9):1244–1252. https://doi.org/10.1001/jama.1992.03480090092034.
Cobb KL, Bachrach LK, Sowers M, Nieves J, Greendale GA, Kent KK, Brown BW, Pettit K, Harper DM, Kelsey JL. The effect of oral contraceptives on bone mass and stress fractures in female runners. Med Sci Sports Exerc. 2007;39(9):1464–73. https://doi.org/10.1249/mss.0b013e318074e532.
Conneely OM, Lydon JP. Progesterone receptors in reproduction: Functional impact of the A and B isoforms. Steroids. 2000;65(10–11):571–7. https://doi.org/10.1016/S0039-128X(00)00115-X.
Cooper DB, Patel P, Mahdy H. Oral contraceptive pills. Hist Intellect Property 50 Objects 2022;224–231. https://doi.org/10.5005/jp/books/12894_19.
Duijkers IJM, Engels L, Klipping C. Length of the menstrual cycle after discontinuation of oral contraceptives. Gynecol Endocrinol Official J Int Soc Gynecol Endocrinol. 2005;20(2):74–9. https://doi.org/10.1080/09513590400021011.
Elliott-Sale KJ, Tenforde AS, Parziale AL, Holtzman B, Ackerman KE. Endocrine effects of relative energy deficiency in sport. Int J Sport Nutr Exerc Metab. 2018;28(4):335–49. https://doi.org/10.1123/ijsnem.2018-0127[doi].
Elliott-Sale KJ, McNulty KL, Ansdell P, Goodall S, Hicks KM, Thomas K. Swinton PA, Dolan E. The effects of oral contraceptives on exercise performance in women: A systematic review and meta-analysis. In: Sports medicine. Berlin: Springer; 2020. p. 1–28 https://doi.org/10.1007/s40279-020-01317-5.
Elliott-Sale KJ, Minahan CL, de Jonge XAKJKJ, Ackerman KE, Sipilä S, Constantini NW, Lebrun CM, Hackney AC Methodological considerations for studies in sport and exercise science with women as participants: A working guide for standards of practice for research on women 2021;51(5). https://pubmed.ncbi.nlm.nih.gov/33725341/.
Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev. 1985;6(3):371–99. https://doi.org/10.1210/EDRV-6-3-371.
Espey E, Ogburn T. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol. 2011;117(3):705–19. https://doi.org/10.1097/AOG.0B013E31820CE2F0.
Ferin M. The menstrual cycle: An integrative view. Reproductive endocrinology, surgery and technology. In: Adashi EYRZ, Rock JA (Eds) 1996.
Fernandez-Fernandez R, Martini AC, Navarro VM, Castellano JM, Dieguez C, Aguilar E, Pinilla L, Tena-Sempere M. Novel signals for the integration of energy balance and reproduction. Mol Cell Endocrinol. 2006;254–255:127–32. https://doi.org/10.1016/j.mce.2006.04.026.
Filicori M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril. 1999;71(3):405–14. https://doi.org/10.1016/S0015-0282(98)00482-8.
Ford O, Lethaby A, Roberts H, Mol BWJ. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev 2012(3). https://doi.org/10.1002/14651858.CD003415.PUB4
Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 μg versus >20 μg estrogen combined oral contraceptives for contraception. In: Cochrane database of systematic reviews, vol. 2013, Issue 8. Cochrane Database systematic review; 2013. https://doi.org/10.1002/14651858.CD003989.pub5.
Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Can Res Cosponsored Am Soc Prev Oncol. 2013;22(11):1931–43. https://doi.org/10.1158/1055-9965.EPI-13-0298.
Golden NH, Carlson JL. The pathophysiology of amenorrhea in the adolescent. Ann N Y Acad Sci. 2008;1135:163–78. https://doi.org/10.1196/ANNALS.1429.014.
Grimes DA, Lopez LM, O’Brien PA. Raymond EG. Progestin-only pills for contraception. Cochrane Database Syst Rev 2013;(11). https://doi.org/10.1002/14651858.CD007541.PUB3.
Hackney AC. Influence of oestrogen on muscle glycogen utilization during exercise. Acta Physiol Scand. 1999;167(3):273–4. https://doi.org/10.1046/j.1365-201X.1999.00605.x.
Hackney AC. Menstrual cycle hormonal changes and energy substrate metabolism in exercising women: A perspective. Int J Environ Res Publ Health 2021;18(19). https://doi.org/10.3390/ijerph181910024.
Hackney AC, Koltun KJ, Williett HN. Menstrual cycle hormonal changes: Estradiol-β-17 and progesterone interactions on exercise fat oxidation. Endocrine. 2022. https://doi.org/10.1007/S12020-022-02998-W.
Hakimi O, Cameron L-C. Effect of exercise on ovulation: A systematic review. Sports Med. 2017;47:1555–67. https://doi.org/10.1007/s40279-016-0669-8.
Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003;28(SUPPL. 3):1–23. https://doi.org/10.1016/S0306-4530(03)00098-2.
Hall JE, Guyton AC. Guyton and hall: Textbook of medical physiology (11th ed). Elsevier-Health Sciences Division;2006.
Henderson, ZJ, Scribbans TD. Intrauterine contraception and athletic performance. Health Fitness J Can, 2020;13(2):37–45. https://doi.org/10.14288/HFJC.V13I2.308
Herbison AE. The gonadotropin-releasing hormone pulse generator. In: Endocrinology, vol. 159, Issue 11. Oxford University Press;2018, p. 3723–36. https://doi.org/10.1210/en.2018-00653
Hillier SG. Intrafollicular paracrine function of ovarian androgen. J Steroid Biochem. 1987;27(1–3):351–7. https://doi.org/10.1016/0022-4731(87)90327-X.
Höök M, Bergström M, Sæther SA, McGawley K. Do elite sport first, get your period back later. Are barriers to communication hindering female athletes? Int J Environ Res Publ Health 2021;18(22). https://doi.org/10.3390/IJERPH182212075.
Inki P, Hurskainen R, Palo P, Ekholm E, Grenman S, Kivelä A, Kujansuu E, Teperi J, Yliskoski M, Paavonen J. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system versus hysterectomy. Ultrasound Obstet Gynecol Official J Int Soc Ultrasound Obstet Gynecol 2002;20(4):381–385. https://doi.org/10.1046/J.1469-0705.2002.00805.X.
Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33. https://doi.org/10.1186/s13293-017-0152-8.
Jones RK. Beyond birth control: the overlooked benefits of oral contraceptive pills 2011. https://sci-hub.do/https://www.guttmacher.org/sites/default/files/report_pdf/beyond-birth-control.pdf?utm_source=baytoday.ca&utm_campaign=baytoday.ca%3Aoutbound&utm_medium=referral
Karapanou O, Papadimitriou A. Determinants of menarche. Reprod Biol Endocrinol. 2010;8(1):1–8. https://doi.org/10.1186/1477-7827-8-115.
Kitaoka M, Kojima I, Ogata E. Activin-A: a modulator of multiple types of anterior pituitary cells. Biochem Biophys Res Commun. 1988;157(1):48–54. https://doi.org/10.1016/S0006-291X(88)80009-3.
Klein DA, Paradise SL, Reeder RM. Amenorrhea: A systematic approach to diagnosis and management. Am Fam Physician. 2019;100(1):39–48. https://doi.org/10.2310/obg.19117.
Knowles OE, Aisbett B, Main LC, Drinkwater EJ, Orellana L, Lamon S. Resistance training and skeletal muscle protein metabolism in eumenorrheic females: Implications for researchers and practitioners. Sports Med. 2019;49(11):1637–50. https://doi.org/10.1007/s40279-019-01132-7.
Kroll R, Reape KZ, Margolis M. The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol. Contraception. 2010;81(1):41–8. https://doi.org/10.1016/J.CONTRACEPTION.2009.07.003.
Lewis RA, Taylor D, Natavio MF, Melamed A, Felix J, Mishell D. Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability. Contraception. 2010;82(6):491–6. https://doi.org/10.1016/J.CONTRACEPTION.2010.06.006.
Lindh I, Skjeldestad FE, Gemzell-Danielsson K, Heikinheimo O, Hognert H, Milsom I, Lidegaard Ø. Contraceptive use in the Nordic countries. Acta Obstet Gynecol Scand. 2017;96(1):19–28. https://doi.org/10.1111/AOGS.13055.
Lopez LM, Steiner M, Grimes DA, Hilgenberg D, Schulz KF. Strategies for communicating contraceptive effectiveness. Cochrane Database Syst Rev 2013;(4). https://doi.org/10.1002/14651858.CD006964.PUB3.
Loucks AB, Thuma JR. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab. 2003;88(1):297–311. https://doi.org/10.1210/jc.2002-020369.
Machado RB, de Melo NR, Maia H. Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study. Contraception. 2010;81(3):215–22. https://doi.org/10.1016/J.CONTRACEPTION.2009.10.010.
MacNutt MJ, De Souza MJ, Tomczak SE, Homer JL, Sheel AW. Resting and exercise ventilatory chemosensitivity across the menstrual cycle. J Appl Physiol. 2012;112(5):737–47. https://doi.org/10.1152/japplphysiol.00727.2011.
Maguire K, Westhoff C. The state of hormonal contraception today: Established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011;205(4):S4. https://doi.org/10.1016/J.AJOG.2011.06.056.
Makanji Y, Zhu J, Mishra R, Holmquist C, Wong WPS, Schwartz NB, Mayo KE, Woodruff TK. Inhibin at 90: From discovery to clinical application, a historical review. Endocr Rev. 2014;35(5):747–94. https://doi.org/10.1210/er.2014-1003.
Mani SK, Blaustein JD, O’Malley BW. Progesterone receptor function from a behavioral perspective. Horm Behav. 1997;31(3):244–55. https://doi.org/10.1006/HBEH.1997.1393.
Martin D, Sale C, Cooper SB, Elliott-Sale KJ. Period prevalence and perceived side effects of hormonal contraceptive use and the menstrual cycle in elite athletes. Int J Sports Physiol Perform. 2018;13(7):926–32. https://doi.org/10.1123/ijspp.2017-0330[doi].
Matsumoto T, Asakura H, Hayashi T. Biopsychosocial aspects of premenstrual syndrome and premenstrual dysphoric disorder. Gynecol Endocrinol Official J Int Soc Gynecol Endocrinol. 2013;29(1):67–73. https://doi.org/10.3109/09513590.2012.705383.
McNatty KP, Makris A, De Grazia C, Osathanondh R, Ryan KJ. The production of progesterone, androgens and oestrogens by human granulosa cells in vitro and in vivo. J Steroid Biochem. 1979;11(1C):775–9. https://doi.org/10.1016/0022-4731(79)90011-6.
McNulty KL, Elliott-Sale KJ, Dolan E, Swinton PA, Ansdell P, Goodall S., Thomas K, Hicks KM. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: A systematic review and meta-analysis. In: Sports medicine. Berlin: Springer;2020. p. 1–15. https://doi.org/10.1007/s40279-020-01319-3.
Meignié A, Duclos M, Carling C, Orhant E, Provost P, Toussaint JF, Antero J. The effects of menstrual cycle phase on elite athlete performance: A critical and systematic review. Frontiers Physiol 2021;12. https://doi.org/10.3389/FPHYS.2021.654585/PDF.
Menses Requires Energy: A Review of How Disordered Eating, Excessive Exercise, and High Stress Lead to Menstrual Irregularities, 42 Clinical Therapeutics 401 (2020). https://doi.org/10.1016/j.clinthera.2020.01.016.
Milman N, Kirchhoff M, JØrgensen T. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol 1992;65(2), 96–102. https://doi.org/10.1007/BF01698138.
Moreno V, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, Walboomers JMM, Herrero R, Franceschi S. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet (london, England). 2002;359(9312):1085–92. https://doi.org/10.1016/S0140-6736(02)08150-3.
Mountjoy M, Sundgot-Borgen J, Burke L, Carter S, Constantini N, Lebrun C, Meyer N, Sherman R, Steffen K, Budgett R, Ljungqvist A. The IOC consensus statement: Beyond the Female athlete triad-relative energy deficiency in sport (RED-S). Br J Sports Med. 2014;48(7):491–7. https://doi.org/10.1136/bjsports-2014-093502.
Muttukrishna S, Tannetta D, Groome N, Sargent I. Activin and follistatin in female reproduction. Mol Cell Endocrinol. 2004;225(1–2):45–56. https://doi.org/10.1016/J.MCE.2004.02.012.
Nahum GG, Kaunitz AM, Rosen K, Schmelter T, Lynen R. Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system. Contraception, 2015;91(5):412–417. https://doi.org/10.1016/J.CONTRACEPTION.2015.01.021.
Overview | Long-acting reversible contraception | Guidance | NICE, (2019) (Testimony of National institute for health and care excellence). https://www.nice.org.uk/guidance/CG30.
Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci. 1993;84(1):95–8. https://doi.org/10.1042/cs0840095.
Piltonen T, Puurunen J, Hedberg P, Ruokonen A, Mutt SJ, Herzig KH, Nissinen A, Morin-Papunen L, Tapanainen JS. Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study. Hum Reprod (oxford, England). 2012;27(10):3046–56. https://doi.org/10.1093/HUMREP/DES225.
Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M (2012). Kisspeptins and reproduction: Physiological roles and regulatory mechanisms. In: Physiological Reviews (Vol. 92, Issue 3, pp. 1235–1316). American Physiological Society Bethesda, MD. https://doi.org/10.1152/physrev.00037.2010
Pirke KM, Schweiger U, Lemmel W, Krieg JC, Berger M. The influence of dieting on the menstrual cycle of healthy young women. J Clin Endocrinol Metab. 1985;60(6):1174–9. https://doi.org/10.1210/jcem-60-6-1174.
Powell A. Choosing the right oral contraceptive pill for teens. Pediatr Clin North Am. 2017;64(2):343–58. https://doi.org/10.1016/J.PCL.2016.11.005.
Practice bulletin no. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol. 2011;118(1):184–96. https://doi.org/10.1097/AOG.0B013E318227F05E.
Redman LM, Scroop GC, Westlander G, Norman RJ. Effect of a synthetic progestin on the exercise status of sedentary young women. J Clin Endocrinol Metab. 2005;90(7):3830–7. https://doi.org/10.1210/JC.2004-2401.
Roa, J., Aguilar, E., Dieguez, C., Pinilla, L., & Tena-Sempere, M. (2008). New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. In Frontiers in Neuroendocrinology (Vol. 29, Issue 1, pp. 48–69). Academic Press. https://doi.org/10.1016/j.yfrne.2007.07.002
Sam S, Frohman LA. Normal physiology of hypothalamic pituitary regulation. Endocrinol Metab Clin North Am. 2008;37(1):1–22. https://doi.org/10.1016/J.ECL.2007.10.007.
Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab. 2013;11(1):41–7. https://doi.org/10.5812/ijem.4158.
Sirola J, Rikkonen T. Muscle performance after the menopause. J Br Menopause Soc. 2005;11(2):45–50. https://doi.org/10.1258/136218005775544561.
Sitruk-Ware, R., & El-Etr, M. (2013). Progesterone and related progestins: potential new health benefits. Climacteric : The Journal of the International Menopause Society, 16 Suppl 1(S1), 69–78. https://doi.org/10.3109/13697137.2013.802556
Sitruk-Ware R, Nath A. Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord. 2011;12(2):63–75. https://doi.org/10.1007/S11154-011-9182-4.
Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update. 2014;20(4):485–500. https://doi.org/10.1093/HUMUPD/DMU009.
Solli GS, Sandbakk SB, Noordhof DA, Ihalainen JK, Sandbakk Ø. Changes in self-reported physical fitness, performance, and side effects across the phases of the menstrual cycle among competitive endurance athletes. Int J Sports Physiol Perform. 2020;15(9):1324–33. https://doi.org/10.1123/ijspp.2019-0616.
Southmayd EA, Hellmers AC, De Souza MJ. Food versus pharmacy: assessment of nutritional and pharmacological strategies to improve bone health in energy-deficient exercising women. Curr Osteoporos Rep. 2017;15(5):459–72. https://doi.org/10.1007/S11914-017-0393-9.
Spencer AL, Bonnema R, McNamara MC. Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications. Am J Med. 2009;122(6):497–506. https://doi.org/10.1016/J.AMJMED.2009.01.016.
Strock NCA, De Souza MJ, Williams NI. Eating behaviours related to psychological stress are associated with functional hypothalamic amenorrhoea in exercising women. J Sports Sci. 2020;38(21):2396–406. https://doi.org/10.1080/02640414.2020.1786297.
Tiihonen, M. (2012). Naisten kokemuksia hormonivalmisteista: tutkimus hormonaalisesta ehkäisystä ja vaihdevuosien hormonihoidosta. https://sci-hub.do/https://erepo.uef.fi/bitstream/handle/123456789/10626/urn_isbn_978-952-61-0683-0.pdf?sequence=1
Torstveit MK, Sundgot-Borgen J. Participation in leanness sports but not training volume is associated with menstrual dysfunction: a national survey of 1276 elite athletes and controls. Br J Sports Med. 2005;39(3):141–7. https://doi.org/10.1136/BJSM.2003.011338.
Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397–404. https://doi.org/10.1016/J.CONTRACEPTION.2011.01.021.
Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev. 2006;27(6):575–605. https://doi.org/10.1210/ER.2005-0020.
Väänänen, H. K., & Härkönen, P. L. (1996). Estrogen and bone metabolism. Maturitas, 23(SUPPL.), S65–S69. https://doi.org/10.1016/0378-5122(96)01015-8
Vande Wiele RL, Bogumil J, Dyrenfurth I, Ferin M, Jewelewicz R, Warren M, Rizkallah T, Mikhail G. Mechanisms regulating the menstrual cycle in women. Recent Prog Horm Res. 1970;26:63–103. https://doi.org/10.1016/B978-0-12-571126-5.50006-6.
Veldhuis JD, Evans WS, Demers LM, Thorner MO, Wakat D, Rogol AD. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J Clin Endocrinol Metab. 1985;61(3):557–63. https://doi.org/10.1210/jcem-61-3-557.
Viña J, Sastre J, Pallardó FV, Gambini J, Borrás C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radical Res. 2006;40(12):1359–65. https://doi.org/10.1080/10715760600952851.
Westhoff CL, Heartwell S, Edwards S, Zieman M, Stuart G, Cwiak C, Davis A, Robilotto T, Cushman L, Kalmuss D. Oral contraceptive discontinuation: Do side effects matter? Am J Obstet Gynecol. 2007;196(4):412.e1-412.e7. https://doi.org/10.1016/J.AJOG.2006.12.015.
Wierman ME. Sex steroid effects at target tissues: Mechanisms of action. Am J Physiol Adv Physiol Educ. 2007;31(1):26–33. https://doi.org/10.1152/ADVAN.00086.2006/ASSET/IMAGES/LARGE/ZU10010723690012.JPEG.
Yonkers KA, O’Brien PS, Eriksson E. Premenstrual syndrome. The Lancet. 2008;371(9619):1200–10. https://doi.org/10.1016/S0140-6736(08)60527-9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mikkonen, R.S., Ihalainen, J.K., Davis-Wilson, H.C., Hackney, A.C. (2023). The Hypothalamic–Pituitary–Ovarian Axis, Menstrual and Oral Contraceptive Cycles: Regulation and Function in the Context of Exercise and Sport. In: Hackney, A.C. (eds) Sex Hormones, Exercise and Women. Springer, Cham. https://doi.org/10.1007/978-3-031-21881-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-031-21881-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-21880-4
Online ISBN: 978-3-031-21881-1
eBook Packages: MedicineMedicine (R0)